Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Nishank Jain

Concepts (169)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Renal Insufficiency, Chronic
18
2024
187
7.910
Why?
Renal Dialysis
11
2025
179
4.670
Why?
Kidney Failure, Chronic
10
2025
210
4.500
Why?
Purinergic P2Y Receptor Antagonists
5
2022
29
3.170
Why?
Thrombosis
5
2024
253
2.340
Why?
Platelet Aggregation Inhibitors
6
2023
181
2.040
Why?
Blood Platelets
3
2024
259
1.990
Why?
Cardiovascular Diseases
5
2022
490
1.740
Why?
Atrial Fibrillation
2
2025
200
1.330
Why?
Anticoagulants
2
2025
270
1.260
Why?
Depressive Disorder, Major
3
2019
148
1.180
Why?
Sertraline
3
2019
44
1.170
Why?
Warfarin
2
2019
84
1.140
Why?
Atrial Appendage
1
2025
14
0.960
Why?
Inflammation
3
2024
641
0.940
Why?
Receptors, Purinergic
1
2024
12
0.890
Why?
Platelet Aggregation
3
2023
72
0.850
Why?
Troponin T
4
2022
12
0.820
Why?
Ticlopidine
3
2023
56
0.800
Why?
Hemorrhage
2
2025
209
0.770
Why?
Humans
32
2025
52483
0.710
Why?
Drug Substitution
1
2019
10
0.640
Why?
Sepsis
1
2021
239
0.600
Why?
Hypocalcemia
1
2017
13
0.560
Why?
Hyperparathyroidism
1
2017
31
0.550
Why?
Parathyroidectomy
1
2017
46
0.540
Why?
Bone Diseases, Metabolic
1
2017
78
0.520
Why?
Self Report
2
2019
210
0.510
Why?
Calcium
2
2017
376
0.510
Why?
Psychiatric Status Rating Scales
1
2016
323
0.480
Why?
Acute Coronary Syndrome
1
2016
80
0.470
Why?
Drinking
1
2014
43
0.460
Why?
Sodium Chloride, Dietary
1
2014
34
0.450
Why?
Aspirin
1
2015
115
0.450
Why?
Primary Prevention
1
2014
45
0.450
Why?
Male
16
2025
26761
0.450
Why?
Dialysis Solutions
1
2014
3
0.450
Why?
Hyperphosphatemia
1
2014
3
0.450
Why?
Phosphate-Binding Proteins
1
2014
7
0.440
Why?
Potassium, Dietary
1
2014
2
0.440
Why?
Natriuretic Peptide, Brain
3
2022
29
0.440
Why?
Middle Aged
11
2023
13028
0.440
Why?
Sodium, Dietary
1
2014
24
0.430
Why?
Platelet Count
2
2024
75
0.430
Why?
Administration, Oral
3
2019
451
0.420
Why?
Treatment Outcome
7
2023
5422
0.420
Why?
Female
15
2025
28171
0.420
Why?
Phosphates
1
2013
49
0.400
Why?
Acid-Base Equilibrium
1
2012
9
0.400
Why?
Aged
8
2025
10121
0.400
Why?
Adiposity
1
2014
143
0.390
Why?
Hyperkalemia
1
2012
12
0.380
Why?
Potassium
1
2012
58
0.380
Why?
Percutaneous Coronary Intervention
1
2016
307
0.380
Why?
Veterans
1
2018
583
0.370
Why?
Cause of Death
4
2019
160
0.360
Why?
Evidence-Based Medicine
1
2012
261
0.360
Why?
Depressive Disorder
1
2012
334
0.330
Why?
Risk Factors
6
2019
3889
0.330
Why?
Glomerular Filtration Rate
4
2019
124
0.320
Why?
Kidney Diseases
1
2012
220
0.320
Why?
Adenosine
2
2023
71
0.320
Why?
Kidney
2
2017
707
0.300
Why?
Pyridones
2
2019
36
0.300
Why?
Retrospective Studies
4
2025
6607
0.290
Why?
Oxidative Stress
1
2013
807
0.290
Why?
Pyrazoles
2
2019
114
0.280
Why?
Prognosis
5
2019
2099
0.280
Why?
Stroke
2
2025
512
0.280
Why?
Prospective Studies
4
2019
2481
0.260
Why?
United States
3
2025
5192
0.250
Why?
Risk Assessment
3
2019
1327
0.250
Why?
Prevalence
2
2019
1006
0.240
Why?
Obesity
1
2014
1162
0.240
Why?
Aged, 80 and over
3
2025
3392
0.240
Why?
Peptide Fragments
2
2017
203
0.240
Why?
Albuminuria
2
2022
49
0.230
Why?
Disease Progression
3
2019
871
0.230
Why?
Time Factors
3
2019
2968
0.230
Why?
Purinergic Antagonists
1
2024
7
0.230
Why?
Antidepressive Agents
2
2017
177
0.220
Why?
Hemostasis
1
2024
60
0.220
Why?
Adult
7
2019
14161
0.200
Why?
Neoplasms
1
2013
1325
0.200
Why?
Coronary Artery Disease
2
2017
294
0.190
Why?
Gastrointestinal Hemorrhage
1
2022
89
0.180
Why?
Dose-Response Relationship, Drug
2
2015
1378
0.170
Why?
Tumor Necrosis Factor-alpha
1
2022
399
0.170
Why?
Double-Blind Method
2
2019
713
0.170
Why?
Hypertrophy, Left Ventricular
2
2017
42
0.170
Why?
Case-Control Studies
1
2023
1201
0.170
Why?
E-Selectin
1
2019
13
0.160
Why?
Intention to Treat Analysis
1
2019
30
0.160
Why?
Arachidonic Acid
1
2019
34
0.160
Why?
Placebos
1
2019
85
0.160
Why?
P-Selectin
1
2019
30
0.160
Why?
Cytokines
1
2022
623
0.160
Why?
Peritoneal Dialysis
1
2019
33
0.160
Why?
Platelet Activation
1
2019
47
0.160
Why?
Drug Utilization
1
2019
78
0.160
Why?
Kruppel-Like Transcription Factors
1
2019
36
0.160
Why?
Xenobiotics
1
2019
31
0.150
Why?
Drug Prescriptions
1
2019
102
0.150
Why?
Fatigue
1
2019
125
0.150
Why?
Proportional Hazards Models
2
2017
443
0.150
Why?
Follow-Up Studies
2
2015
2279
0.150
Why?
Needs Assessment
1
2019
140
0.150
Why?
International Normalized Ratio
1
2018
28
0.150
Why?
Antidotes
1
2018
27
0.150
Why?
Antithrombins
1
2018
19
0.150
Why?
Thiazoles
1
2018
55
0.150
Why?
Patient Selection
1
2019
259
0.140
Why?
Hyperparathyroidism, Secondary
1
2017
4
0.140
Why?
Calcitriol
1
2017
39
0.140
Why?
Vascular Calcification
1
2017
19
0.140
Why?
Signal Transduction
1
2024
1671
0.140
Why?
Pyridines
1
2018
132
0.130
Why?
Bone Density Conservation Agents
1
2017
75
0.130
Why?
Survival Rate
1
2019
945
0.130
Why?
Syndrome
1
2017
247
0.130
Why?
Young Adult
2
2019
4329
0.130
Why?
Diphosphonates
1
2017
92
0.130
Why?
Registries
1
2019
581
0.130
Why?
Texas
2
2017
143
0.130
Why?
Platelet Function Tests
1
2015
17
0.130
Why?
Animals
3
2024
13505
0.130
Why?
ROC Curve
1
2016
253
0.120
Why?
Diet, Sodium-Restricted
1
2014
5
0.120
Why?
Drug Therapy, Combination
1
2015
395
0.110
Why?
Calcinosis
1
2014
51
0.110
Why?
Nutrition Surveys
1
2014
117
0.110
Why?
Linear Models
1
2014
287
0.100
Why?
Phosphorus, Dietary
1
2013
3
0.100
Why?
Aging, Premature
1
2013
5
0.100
Why?
Triglycerides
1
2014
165
0.100
Why?
Feeding Behavior
1
2014
192
0.100
Why?
Alcohol Drinking
1
2014
237
0.100
Why?
Longevity
1
2013
85
0.100
Why?
Models, Animal
1
2013
234
0.100
Why?
Hospitalization
1
2016
736
0.090
Why?
DNA Repair
1
2013
195
0.090
Why?
Randomized Controlled Trials as Topic
1
2014
595
0.090
Why?
Sex Factors
1
2014
727
0.090
Why?
Patient Education as Topic
1
2014
321
0.090
Why?
Blood Pressure
1
2014
537
0.090
Why?
Blood Glucose
1
2014
473
0.090
Why?
Body Mass Index
1
2014
689
0.090
Why?
Heart Diseases
1
2011
216
0.080
Why?
Diet
1
2013
587
0.070
Why?
Adolescent
1
2019
6739
0.070
Why?
Aging
1
2013
701
0.070
Why?
Longitudinal Studies
2
2019
747
0.060
Why?
Electrophoretic Mobility Shift Assay
1
2019
74
0.040
Why?
Down-Regulation
1
2019
346
0.040
Why?
Survival Analysis
1
2019
673
0.030
Why?
Cell Line
1
2019
1030
0.030
Why?
Mice, Knockout
1
2019
879
0.030
Why?
Kaplan-Meier Estimate
1
2017
483
0.030
Why?
Severity of Illness Index
1
2019
1026
0.030
Why?
Coronary Angiography
1
2017
367
0.030
Why?
Carotid Intima-Media Thickness
1
2014
10
0.030
Why?
Predictive Value of Tests
1
2017
944
0.030
Why?
Mice, Inbred C57BL
1
2019
1884
0.030
Why?
Ventricular Dysfunction, Left
1
2014
108
0.030
Why?
Depression
1
2017
600
0.020
Why?
Quality of Life
1
2017
879
0.020
Why?
Magnetic Resonance Imaging
1
2017
1546
0.020
Why?
Tomography, X-Ray Computed
1
2014
1165
0.020
Why?
Mice
1
2019
5949
0.020
Why?
Jain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description